Similar articles for PMID: 26147240

Year	Number of Results
2003	1
2004	2
2005	1
2006	1
2007	1
2008	1
2009	4
2010	7
2011	8
2012	6
2013	18
2014	22
2015	15
2016	5
2017	12
2018	6
2019	13
2020	3
2021	4
2022	1
2023	1
2024	0

1

Discovery of New H2S Releasing Phosphordithioates and 2,3-Dihydro-2-phenyl-2-sulfanylenebenzo[d][1,3,2]oxazaphospholes with Improved Antiproliferative Activity.

Feng W, Teo XY, Novera W, Ramanujulu PM, Liang D, Huang D, Moore PK, Deng LW, Dymock BW. Feng W, et al. J Med Chem. 2015 Aug 27;58(16):6456-80. doi: 10.1021/acs.jmedchem.5b00848. Epub 2015 Aug 5. J Med Chem. 2015. PMID: 26147240

2

Discovery of medium ring thiophosphorus based heterocycles as antiproliferative agents.

Feng W, Novera W, Peh K, Neo D, Ramanujulu PM, Moore PK, Deng LW, Dymock BW. Feng W, et al. Bioorg Med Chem Lett. 2017 Feb 15;27(4):967-972. doi: 10.1016/j.bmcl.2016.12.079. Epub 2017 Jan 2. Bioorg Med Chem Lett. 2017. PMID: 28082040

3

GYY4137, a novel water-soluble, H2S-releasing molecule.

Rose P, Dymock BW, Moore PK. Rose P, et al. Methods Enzymol. 2015;554:143-67. doi: 10.1016/bs.mie.2014.11.014. Epub 2015 Jan 10. Methods Enzymol. 2015. PMID: 25725521 Free article. Review.

4

Role of H2S Donors in Cancer Biology.

Lee ZW, Deng LW. Lee ZW, et al. Handb Exp Pharmacol. 2015;230:243-65. doi: 10.1007/978-3-319-18144-8_13. Handb Exp Pharmacol. 2015. PMID: 26162839 Review.

5

Biological Effects of Morpholin-4-Ium 4 Methoxyphenyl (Morpholino) Phosphinodithioate and Other Phosphorothioate-Based Hydrogen Sulfide Donors.

Nin DS, Idres SB, Song ZJ, Moore PK, Deng LW. Nin DS, et al. Antioxid Redox Signal. 2020 Jan 10;32(2):145-158. doi: 10.1089/ars.2019.7896. Antioxid Redox Signal. 2020. PMID: 31642346 Review.

6

The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.

Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, Moore PK, Deng LW. Lee ZW, et al. PLoS One. 2011;6(6):e21077. doi: 10.1371/journal.pone.0021077. Epub 2011 Jun 20. PLoS One. 2011. PMID: 21701688 Free PMC article.

7

Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors.

Whiteman M, Perry A, Zhou Z, Bucci M, Papapetropoulos A, Cirino G, Wood ME. Whiteman M, et al. Handb Exp Pharmacol. 2015;230:337-63. doi: 10.1007/978-3-319-18144-8_17. Handb Exp Pharmacol. 2015. PMID: 26162843 Review.

8

Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.

Xu S, Liu Z, Liu P. Xu S, et al. Int J Cardiol. 2014 Mar 15;172(2):313-7. doi: 10.1016/j.ijcard.2014.01.068. Epub 2014 Jan 24. Int J Cardiol. 2014. PMID: 24491853 Review.

9

Toxicity, bioactivity, release of H₂S in vivo and pharmaco-kinetics of H₂S-donors with thiophosphamide structure.

Zhang J, Zhang Q, Wang Y, Li J, Bai Z, Zhao Q, He D, Wang Z, Zhang J, Chen Y. Zhang J, et al. Eur J Med Chem. 2019 Aug 15;176:456-475. doi: 10.1016/j.ejmech.2019.05.017. Epub 2019 May 11. Eur J Med Chem. 2019. PMID: 31128448

10

H₂S-Releasing Polymer Micelles for Studying Selective Cell Toxicity.

Foster JC, Radzinski SC, Zou X, Finkielstein CV, Matson JB. Foster JC, et al. Mol Pharm. 2017 Apr 3;14(4):1300-1306. doi: 10.1021/acs.molpharmaceut.6b01117. Epub 2017 Mar 16. Mol Pharm. 2017. PMID: 28300411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year